12:00 AM
Nov 08, 1999
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Squalamine: Began Phase IIa testing

Squalamine is in Phase II testing to treat advanced non-small cell lung cancer.

(Preclinical data, B12)

Magainin Pharmaceuticals Inc. (MAGN), Plymouth Meeting, Penn.
Product: Squalamine
Business: Cancer...

Read the full 122 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >